Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.69% |
| 2 | Industrials | 9.96% |
| 3 | Consumer Discretionary | 8.03% |
| 4 | Healthcare | 7.46% |
| 5 | Financials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Braze
BRZE
$3.5B
| $8.35M | 0.01% |
+385,014
| New | +$8.57M |
|
1077
Comstock Resources
CRK
$4.18B
| $8.32M | 0.01% |
557,763
+506,065
| +979% | +$7.74M |
|
1078
ARK Innovation ETF
ARKK
$6.72B
| $8.29M | 0.01% |
+102,541
| New | +$7.84M |
|
1079
PUT
Futu Holdings
FUTU
$17.3B
| $8.29M | 0.01% |
88,400
-15,100
| -15% | -$1.93M |
|
1080
Ascendis Pharma A/S
ASND
$16.6B
| $8.27M | 0.01% |
+31,023
| New | +$7.25M |
|
1081
Generac Holdings
GNRC
$12.2B
| $8.26M | 0.01% |
28,214
+24,478
| +655% | +$6.13M |
|
1082
PUT
Analog Devices
ADI
$182B
| $8.26M | 0.01% |
20,800
+1,300
| +7% | +$515K |
|
1083
Interface
TILE
$2.25B
| $8.26M | 0.01% |
230,334
-49,918
| -18% | -$1.46M |
|
|
DRAM
1084
Roundhill Memory ETF
DRAM
$27.1B
| $8.25M | 0.01% |
+111,707
| New | +$5.82M |
|
1085
AXT Inc
AXTI
$4.64B
| $8.24M | 0.01% |
+114,386
| New | +$10.3M |
|
1086
CALL
Globalstar
GSAT
$10.7B
| $8.24M | 0.01% |
+101,400
| New | +$8.16M |
|
1087
Integer Holdings
ITGR
$4.26B
| $8.24M | 0.01% |
88,172
-132,402
| -60% | -$11.8M |
|
1088
Western Union
WU
$2.28B
| $8.24M | 0.01% |
1,070,067
-378,693
| -26% | -$3.18M |
|
1089
PUT
Simon Property Group
SPG
$70.6B
| $8.21M | 0.01% |
36,700
+700
| +2% | +$144K |
|
1090
Arhaus
ARHS
$1.33B
| $8.2M | 0.01% |
973,645
-76,343
| -7% | -$530K |
|
1091
Takeda Pharmaceutical
TAK
$58.1B
| $8.2M | 0.01% |
511,336
+370,758
| +264% | +$6.14M |
|
1092
PUT
Shopify
SHOP
$192B
| $8.19M | 0.01% |
71,700
+23,600
| +49% | +$2.69M |
|
1093
TTM Technologies
TTMI
$11.6B
| $8.18M | 0.01% |
43,746
-94,287
| -68% | -$15.2M |
|
1094
CALL
Mastercard
MA
$509B
| $8.17M | 0.01% |
15,900
+12,700
| +397% | +$6.33M |
|
1095
Rogers Communications
RCI
$19.6B
| $8.16M | 0.01% |
251,031
+156,628
| +166% | +$5.65M |
|
1096
PUT
Johnson & Johnson
JNJ
$651B
| $8.15M | 0.01% |
32,100
+4,500
| +16% | +$1.05M |
|
1097
CALL
Organon & Co
OGN
$3.61B
| $8.12M | 0.01% |
+600,000
| New | +$7.17M |
|
1098
Norwegian Cruise Line
NCLH
$7.92B
| $8.11M | 0.01% |
384,189
+370,133
| +2,633% | +$6.91M |
|
1099
Delta Air Lines
DAL
$54.2B
| $8.11M | 0.01% |
86,573
+76,878
| +793% | +$5.8M |
|
|
BCPC
1100
Balchem Corp
BCPC
$5.78B
| $8.1M | 0.01% |
47,936
+9,326
| +24% | +$1.55M |
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $7.14B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.7% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.